news.sky.com
🌐 75% Global Worthiness
NICE Approves New Drug for Severe Dust Mite Allergy
NICE has approved Acarizax, a new drug for people aged 12-65 in England with persistent moderate to severe house dust mite allergic rhinitis whose symptoms are not controlled by standard treatments; approximately 13,000 people could benefit from this first-of-its-kind treatment.
NICE Approves New Drug for Severe Dust Mite Allergy
NICE has approved Acarizax, a new drug for people aged 12-65 in England with persistent moderate to severe house dust mite allergic rhinitis whose symptoms are not controlled by standard treatments; approximately 13,000 people could benefit from this first-of-its-kind treatment.
Progress
48% Bias Score
Good Health and Well-being